Birdwatch Note Rating
2023-08-20 21:19:13 UTC - HELPFUL
Rated by Participant: C18576CBE28938D330850DAD19DFB4AEDA8B8CED5D79BA849282CBEDB06CD0E9
Participant Details
Original Note:
NNN. Personal opinion. To date, at least 3 pharmacovigilance analyses suggest potential kidney damage associated with remdesivir use. https://pubmed.ncbi.nlm.nih.gov/33340409/ https://pubmed.ncbi.nlm.nih.gov/34787281/ https://pubmed.ncbi.nlm.nih.gov/35401177/ According to the FDA, one of the most common adverse reactions is increased ALT, associated with liver injury or disease. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214787s019lbl.pdf
All Note Details